Viewing nowDonepezil Hydrochloride 5mg Tablets
Donepezil Hydrochloride Hydrate 5.22mg
Tablet · Prescription medication
Selbion Co., Ltd.

MFDS item code 201707537 · Approved 2017.10.20 · Insurance code 055800150
Treatment of symptoms of Alzheimer-type dementia
This medication is used for the treatment of Alzheimer’s dementia symptoms. It helps to improve memory decline, cognitive dysfunction, and difficulties in daily activities.
Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg once daily, administer with caution for gastrointestinal adverse reactions. After discontinuation of this medicine, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. Women aged 85 years or older who are underweight: Careful monitoring is required because adverse reactions occur more frequently. Underweight elderly women should not exceed 5 mg once daily.
Pediatric patients: There is no experience with use in children.
This medication is used to alleviate the symptoms of Alzheimer’s dementia, with Donepezil Hydrochloride as its main ingredient. This medication should not be used by certain patients. For example, individuals who are allergic to this medication or its ingredients, pregnant or potentially pregnant women, and breastfeeding women should not take this medication. Additionally, individuals with lactose intolerance or certain genetic metabolic disorders should also avoid this medication. Patients with heart disease or cardiac conduction disorders should be cautious when taking this medication, as bradycardia or arrhythmia might occur. Patients taking non-steroidal anti-inflammatory drugs or those with a history of peptic ulcers should use this medication carefully, as it can increase gastric acid secretion and enhance gastrointestinal motility, potentially worsening symptoms. Patients with a history of asthma or obstructive pulmonary disease should also be cautious, as respiratory symptoms may worsen with this medication. Patients with extrapyramidal disorders such as Parkinson's disease should consult their doctor before using this medication, as it may worsen their symptoms. Diverse adverse reactions may occur when using this medication, and in severe cases, cardiac issues, gastrointestinal bleeding, liver dysfunction, cerebrovascular problems, muscle disorders, and respiratory difficulties may arise; if symptoms worsen, medical attention should be sought immediately. Additionally, symptoms such as dizziness, nausea, vomiting, diarrhea, insomnia, hallucinations, and depression may occur, hence caution is advised. This medication is approved for use only in Alzheimer’s dementia patients and should not be used for other types of dementia or memory disorders. While on this medication, regular assessments of treatment efficacy should be performed, and if ineffective or if there are severe side effects, treatment discontinuation should be considered. Patients with heart disease or electrolyte imbalances may require cardiac monitoring. This medication may affect driving or machine operation ability; thus, caution is needed during the initial stages of treatment or if the dosage is changed. This medication may interact with specific drugs, so patients taking other medications should definitely consult their physician or pharmacist. It is safer for pregnant or breastfeeding women to avoid using this medication, and if necessary, breastfeeding should be discontinued. Safety in children has not been established; therefore, it should not be used in children. In the case of an overdose, serious symptoms such as nausea, vomiting, bradycardia, and respiratory suppression may occur, which requires immediate emergency treatment. This medication must be kept out of the reach of children and should not be transferred to other containers.
Syncope, bradycardia, heart block, prolonged QT interval, myocardial infarction, heart failure, peptic ulcer, perforated duodenal perforation, gastrointestinal bleeding, hepatitis, liver dysfunction, jaundice, cerebral seizure, intracerebral hemorrhage, cerebrovascular disorders, motor dysfunction, ataxia, movement disorders, dystonia, tremor, involuntary movements, gait disorder, abnormal posture, speech disorder, akinetic mutism, severe muscle rigidity, dysphagia, tachycardia, blood pressure fluctuations, sweating, myalgia, weakness, dyspnea, acute pancreatitis, acute kidney failure, sudden death, cold, loss of appetite, hallucinations, agitation, aggressive behavior, anxiety disorder, insomnia, drowsiness, increased libido, talkativeness, mania, nightmares, irritability, gibberish, delusions, depression, confusion, indifference, hyperactivity, hypersexuality, dizziness, tremor, seizures, stupor, chest rigidity, palpitations, sinoatrial block, atrioventricular block, hypertension, hypotension, atrial fibrillation, torsades de pointes, QT interval prolongation on electrocardiogram, diarrhea, nausea, vomiting, abdominal disorders, gastrointestinal bleeding, gastro-duodenal ulcer, constipation, salivation, fecal incontinence, liver dysfunction including hepatitis, rash, itching, muscle spasms, myalgia, urinary incontinence, increased urination, urinary retention, headache, fatigue, pain, toothache, facial flushing, malaise, asthenia, edema, fever, decreased body temperature, decreased hematocrit, leukopenia, anemia, thrombocytopenia, petechial hemorrhage, abnormal dreams, thoughts, headache, back pain, chest pain, bleeding, eczema, urinary incontinence, increased CPK, dehydration, hyperlipidemia, agitation, cholecystitis, confusion, convulsions, hemolytic anemia, hyponatremia, neuroleptic malignant syndrome, pancreatitis, skin rash, cardiac arrest
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that prevents air from entering, and it is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication’s efficacy and prevents deterioration.
This medication is a white, round film-coated tablet.
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 5.22mg
Tablet · Prescription medication
Selbion Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.